Literature DB >> 23290133

Making healthy stem cells: the new role of TPO.

Susumu Goyama1, James C Mulloy.   

Abstract

Thrombopoietin (TPO) attracts much attention as an effective stimulus for blood cell formation in patients with hematopoietic disorders. In this issue of Cell Stem Cell, de Laval et al. (2013) show that TPO can also promote "healthy" hematopoietic stem cells when administered before radiotherapy to minimize HSC injury and mutagenesis in mice.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290133     DOI: 10.1016/j.stem.2012.12.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  2 in total

1.  Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial.

Authors:  Qin Wu; Jianan Ren; Gefei Wang; Guosheng Gu; Dong Hu; Song Liu; Gunawei Li; Jun Chen; Ranran Li; Zhiwu Hong; Huajian Ren; Xiuwen Wu; Yuan Li; Min Yao; Yunzhao Zhao; Jieshou Li
Journal:  Trials       Date:  2015-05-19       Impact factor: 2.279

2.  Mild hypoxia and human bone marrow mesenchymal stem cells synergistically enhance expansion and homing capacity of human cord blood CD34+ stem cells.

Authors:  Fatemeh Mohammadali; Saeid Abroun; Amir Atashi
Journal:  Iran J Basic Med Sci       Date:  2018-07       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.